
LediHep
Molecular Salt: Sofosbuvir / Ledipasvir
LediHep (Ledipasvir 90 mg plus Sofosbuvir 400 mg) is a combinational drug intended for patients suffering from Hepatitis C viral (HCV) infection with genotype 1 or 4. The combination imparts unique properties in HCV patients like,
• • A sustained virologic response (SVR) in between 93% to 99% after 12 weeks of treatment
• • Assist in HCV infection along with infection caused by HIV
Both ledipasvir and sofosbuvir are direct-acting antiviral (DAA) drugs assisting in reducing the viral load in the body. Both the molecules selectively inhibit a crucial protein used for multiplication (RNA replication and virion assembly) of viral cells. The HCV NS5A protein is inhibited by ledipasvir whereas sofosbuvir inhibits the HCV NS5B protein.
Note: Earlier therapy mentioned in the table includes a failed therapy which consists of,
• • Peginterferon/ribavirin
• • Peginterferon alfa/ribavirin/HCV protease inhibitor
Other properties of the FDC combination drug:
Once swallowed, ledipasvir takes about 4 hours and 30 minutes to completely absorb (bio-available) whereas sofosbuvir takes 30 minutes to 2 hours roughly. After entering the system, the binding affinity of ledipasvir (99.8%) is greater than sofosbuvir (61% to 65%). Once all activities are done, the approximate time for 50% of the drug to be expelled out from the body is 47 hours and 40 minutes to 27 hours for ledipasvir and sofosbuvir respectively.
When should LediHep (ledipasvir 90mg + sofosbuvir 400mg) be avoided or used cautiously?
• • If the patient has taken the ledipasvir and sofosbuvir combinational drug, within 4 hours avoid taking any antacid (acidity) drug
• • Avoid having intercourse (sex) without condoms, HCV may spread to your partner if you are under treatment
• • If patients are suffering from or had a history of Hepatitis B viral infection
• • If patients feel their heartbeat is very slow (bradycardia), immediately consult your doctor
• • If patients are taking any sort of non-prescribed or prescribed drugs, herbal medicines, or dietary supplementary
• • If patients are allergic to food, medicines or other substances
• • If patients are suffering from kidney disease or undergoing dialysis or other severe medical condition
• • If patients had a liver transplant before the initiation of dosage
• • If patients have complications in the liver other than HCV infection
• • If patients are pregnant and planning to breastfeed
Side-effects of LediHep (ledipasvir 90mg + sofosbuvir 400mg):
Most common side-effects:
• • Headache
• • Tiredness (Fatigue)
Severe side-effects: Slow heart-rate (bradycardia)
Severe allergic reactions:
• • Rashes and itching on the skin
• • Difficulty in breathing (Dyspnea)
• • Chest tightness
• • Swelling in the mouth, face, lips, or tongue
Uncommon side-effects:
• • Diarrhea
• • Nausea
• • Lack of sleep (Insomnia)
• • General weakness
Note: These are not all possible side-effects of LediHep (ledipasvir 90mg + sofosbuvir 400mg), please ask your doctor for more information regarding the same.
Zydus
(90MG/400MG)
28 Tablets
Store below 30°C
Product Enquiry
Submit an enquiry for wholesale sourcing, pricing, and cold-chain delivery. Our team responds within 24 hours.
Clinical Advisory & Import Compliance
Disclaimer: Gandhi Medicos is a clinical specialty supplier and exporter. All enquiries are subject to valid licensing verification and import permits standard under target jurisdiction guidelines.
Storage Warning: Biological injectables, biosimilars, and active oncology agents are flagged as temperature-sensitive cargo and are packed strictly inside thermal containers coupled with real-time digital temperature tags.

Brand: Zydus